Pharmaceutical compositions containing botulinum neurotoxin
AssigneeAllergan, Inc.
InventorTerrence J. Hunt
Life of this patent
Estimating the term…
Abstract
This invention relates to the use of a composition comprising a polysaccharide and a botulinum toxin for reducing a skin wrinkle. In some embodiments, the polysaccharide comprises disaccharides. In some embodiments, the average molecular weight of a disaccharide unit of the polysaccharide is between about 345 D and about 1,000 D.
Claims5
A device comprising at least two chambers, wherein a first chamber comprises an acidic solution of Botulinum toxin, and a second chamber comprises a buffering solution, wherein the buffering solution is present in an amount sufficient to raise the pH of the acidic botulinum toxin solution to at or near physiological pH after mixing.
Dependencies are inferred from the claim text.